Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity.
A positive correlation between the level of ICAM-1 in serum and the stage of neoplastic processes has been demonstrated. We studied ICAM-1 serum concentration in 27 colorectal cancer patients and investigated the effect of this molecule on cellular aggregation and toxicity. ICAM-1 serum concentration in the group of patients was significantly higher (P < 0.01) than in normal controls and was related to tumour stage. Patient sera inhibited both the formation of cellular aggregates and the percentage of specific lysis, the effect being lost when the serum was depleted of ICAM-1. These results suggest that the release of soluble ICAM-1 may represent a mechanism of tumour escape.
Sánchez-Rovira
P
P
Medical Oncology Department, Reina Sofia University Hospital, Córdoba, Spain.
Jimenez
E
E
Carracedo
J
J
Barneto
I C
IC
Ramirez
R
R
Aranda
E
E
D000368:Aged; D002449:Cell Aggregation / Q000276:immunology; D015179:Colorectal Neoplasms / Q000097:blood* / Q000276:immunology / Q000473:pathology; D003602:Cytotoxicity, Immunologic / Q000502:physiology; D005260:Female; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D019139:Tumor Escape / Q000276:immunology*
D018799:Intercellular Adhesion Molecule-1